ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 467

Serum Long-chain n-3 and -6 Fatty Acids Are Associated with Disease Feature at Onset and with 6-month Disease Activity in Early RA: Results from the ESPOIR Cohort

Johanna Sigaux 1, Camille Buscail 2, Chantal Julia 3, René-Marc Flipo 4, Alain Cantagrel 5, Bernard Bannwarth 6, Francois Laporte 7, Salima Challal 8, Marie-Christophe Boissier 9 and Luca Semerano10, 1INSERM UMR 1125, Université Paris 13, Bobigny, France, 2Equipe de Recherche en Epidémiologie Nutritionnelle (EREN) UMR U1153 Inserm/U1125 Inra/Cnam/Univ Paris 13 Centre de Recherche en Epidémiologie et Biostatistiques UFR SMBH, Bobigny, France, 3uipe de Recherche en Epidémiologie Nutritionnelle (EREN) UMR U1153 Inserm/U1125 Inra/Cnam/Univ Paris 13 Centre de Recherche en Epidémiologie et Biostatistiques UFR SMBH, Bobigny, France, 4Roger Salengro University-Hospital, Lille , France, Lille, France, 5Centre de Rhumatologie, CHU de Toulouse, 31059, Toulouse, France, Toulouse, France, 6Service de rhumatologie, hôpital Pellegrin, centre hospitalier universitaire de Bordeaux, Bordeaux, France, 7Département de Biochimie- Pharmacologie-Toxicologie CHU de Grenoble, Grenoble, France, 8Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne Service de Rhumatologie, Bobigny, France, 9Assistance Publique-Hôpitaux de Paris (AP-HP), Rheumatology Department, Avicenne Hospital, Bobigny, France, 10INSERM UMR 1125 , Université Paris 13, Bobigny, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Early Rheumatoid Arthritis and polyunsaturated fatty acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Long-chain polyunsaturated fatty acids (PUFAs) of the n3 and n6 families can contribute to modulate inflammatory processes. Dietary intake of n3PUFA is inversely associated with the incidence of RA in different populations. In subject at risk of developing RA, a high erythrocyte content in long-chain n3-PUFA is associated with lower ACPA prevalence and less progression to RA. While long-chain n6PUFA are considered mainly proinflammatory, the erythrocyte content in n6 linoleic acid was inversely associated with the development of RA in a nested-case control study. This study aims to characterize serum profiles of PUFA and to determine their association with baseline variables, with 6-month disease activity and 2-year radiographic progression in a cohort of patients with early RA.

Methods: Serum PUFAs were quantified by gas chromatography-mass spectrometry in 594 patients with early RA at recruitment in the French ESPOIR cohort. Cluster analysis on 19 serum fatty acids with 14 to 22 carbon atoms allowed to determine 3 patterns of baseline serum PUFA. Pattern 1 included high proportions of n7 and n9 PUFA, pattern 2 was high in n3 long-chain PUFA (EPA et DHA), pattern 3 was rich in n6 long-chain PUFA. Those patterns were not mutually exclusive (i.e. each patient could fit at different level into different profiles). Patients were stratified in tertiles according to how much the fitted into the pattern (tertile 1 meaning lowest and tertile 3 highest fitting into the pattern). The association of PUFA patterns with baseline variables was tested at univariate analysis. The association with 6-month high disease activity (DAS28 >5.1) was tested at multivariate analysis after adjustment on baseline CRP, corticosteroid and/or NSAIDs, socioeconomic status, ACPA, RF, traditional and biologic DMARDs treatment between 0 and 6 months after inclusion. The same model was used to test the association with 2-year radiographic progression.

Results: At baseline, pattern 1 was associated with high BMI, active smoking and with non-Caucasian origin (table 1). Profile 2 was associated with higher socioeconomic status and inversely associated with DAS28 and CRP. Profile 3 was associated with ACPA positivity and higher baseline CRP. At multivariate analysis, fitting into pattern 2 or 3 was associated with lower odds of having active disease after 6 months (OR for tertile 3 vs. tertile 1:  0.49 (95% CI 0.25 to 0.97, p< 0.05) for pattern 2 and 0.51 (0.28 to 0.95) for pattern 3, respectively). None of the patterns associated with 6-month disease activity was associated with 2-year radiographic progression.

Conclusion: In a cohort of early RA patients, we identified a favorable high serum long-chain n3PUFA profile, associated with low baseline inflammation and persistently low disease activity between 0 and 6 months of follow-up in the cohort. This is consistent with a presumed immunomodulatory action of n3PUFA. Despite a clear baseline association with disease severity features, like ACPA positivity and high CRP, a high serum long-chain n6PUFA profile was also associated with 6-month lower disease activity. Despite the longitudinal association with disease activity, none of the baseline PUFA patterns predicted radiographic progression.  


Table 1 Baseline association between PUFA patterns and patient variables


Disclosure: J. Sigaux, None; C. Buscail, None; C. Julia, None; R. Flipo, MSD, 5, Sanofi, 5; A. Cantagrel, None; B. Bannwarth, None; F. Laporte, None; S. Challal, None; M. Boissier, None; L. Semerano, None.

To cite this abstract in AMA style:

Sigaux J, Buscail C, Julia C, Flipo R, Cantagrel A, Bannwarth B, Laporte F, Challal S, Boissier M, Semerano L. Serum Long-chain n-3 and -6 Fatty Acids Are Associated with Disease Feature at Onset and with 6-month Disease Activity in Early RA: Results from the ESPOIR Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/serum-long-chain-n-3-and-6-fatty-acids-are-associated-with-disease-feature-at-onset-and-with-6-month-disease-activity-in-early-ra-results-from-the-espoir-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-long-chain-n-3-and-6-fatty-acids-are-associated-with-disease-feature-at-onset-and-with-6-month-disease-activity-in-early-ra-results-from-the-espoir-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology